IntraBon PRP: Advanced Therapeutic Strategies in Regenerative Medicine

IntraBon PRP represents a paradigm shift in regenerative medicine by directly targeting the subchondral bone microenvironment to achieve superior therapeutic outcomes compared to conventional intra-articular approaches. This innovative delivery method leverages the unique biological properties of bone marrow, including rich mesenchymal stem cell populations, extensive vascular networks, and enhanced growth factor retention, to maximize the regenerative potential of autologous platelet concentrates. Clinical evidence demonstrates that IntraBon PRP provides enhanced biomarker modulation with significant reductions in inflammatory markers and bone/cartilage turnover markers, while improving pain and functional outcomes across diverse applications including osteoarthritis, avascular necrosis, non-union fractures, dental implantology, and sports medicine injuries.

Dr. Mikhail Artamonov is 8-times Board certified physician specializing in interventional,

functional and regenerative therapies. He is the Founder and President of the American

Society of Medical Gases and the World Congress of Intraosseous Therapy.

He is the creator of several unique applications of IntraBon™ - series of Intraosseous

therapy methods including Spinal Dialysis™, Intraosseous Photodynamic Therapy™,

and End-Plate™ method and publishes extensively on those topics.

DrA spends significant time on his volunteer work as a Chief Medical Officer of

Advocates for Disabled Veterans. He is a father of three and in his rare spare time

enjoys qigong and meditation.